Phase 3: optimized combination (week 11 onward) At this point the combination is running smoothly and the focus shifts to optimization and sustainability
However, in contrast to anti-hyperlycemic agents such as metformin, pioglitazone and peroxisome proliferator-activated receptor gamma (PPAR) agonists, which were particularly well studied in this matter, very few clinical studies concerning the effects of GLP-1R targeting therapeutics on alleviation of depressive symptoms in humans have been carried out so far [118, 119]
It also reduces glucagon, a hormone that raises blood sugar by prompting the liver to release stored glucose
The effect of retatrutide on bone density is also yet to be seen, although other GLP-1s have been shown to cause a decrease in bone density proportional to weight loss
Hair density and thickness is an area some users report improvement GHK-Cu has clinical research around hair follicle regeneration
We did not observe statistically significant correlations between plasma glucose and glucagon, GLP-1, or GIP, respectively (Fig
.png)
